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Microinfarcts in an older population-representative brain donor cohort (MRC CFAS): Prevalence,
relation to dementia and mobility, and implications for the evaluation of cerebral Small Vessel
Disease
Introduction: Microinfarcts, small ischaemic foci com-
mon in ageing brain, are associated with dementia
and gait dysfunction. We determined their relationship
with dementia, mobility and cerebrovascular disease in
an older population-representative brain donor cohort.
These data on microinfarcts were evaluated in relation
to pathological assessments of clinically significant
cerebral small vessel disease (SVD). Methods: Microin-
farcts were assessed in the MRC Cognitive Function
and Ageing Study (n = 331). Nine brain areas were
staged according to the number of areas affected.
Results: 36% of brains showed at least 1 microinfarct.
Higher cortical microinfarct stage was associated with
dementia at death (OR 1.41, 95% CI 1.02; 1.96,
P = 0.038), whilst cortical and subcortical microinfarct
stages were associated with impaired mobility (OR
1.36, 95% CI 1.05–1.74; P 0.018) and falls (OR 1.96,
95% CI 1.11–3.43; P = 0.02). Adding data on
microinfarcts to a definition of SVD, based on white
matter lesions (WMLs), lacunes and significant arte-
riosclerosis, were assessed by comparing area under
ROC curve (AUC) with and without microinfarcts. SVD
was significantly related to dementia status with or
without inclusion of microinfarcts. Modelling potential
pathological definitions of SVD to predict dementia or
impaired mobility indicated optimal prediction using
combined assessment of WMLs, lacunes and microin-
farcts. Conclusion: Cortical (dementia) and subcortical
microinfarcts (impaired mobility) are related to diverse
clinical outcomes. Optimal pathological assessment of
significant SVD in brain ageing is achieved based on
WMLs, lacunes and microinfarcts and may not require
subjective assessment of the extent and severity of
arteriosclerosis.
Keywords: microinfarct, dementia, small vessel disease, white matter lesions, lacunes, vascular risk factors, mobility,
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Introduction
In neuropathological practice the term ‘microinfarct’ is
used to describe CNS lesions of presumed ischaemic
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origin that are only detected by microscopic examina-
tion [1]. Such lesions are a common finding at autopsy
in older individuals [2]. They are typically considered
to measure less than 1 mm in maximum diameter,
although no consensus definition exists, and are fre-
quently much smaller. Anatomically they are encoun-
tered in the cerebral cortex, white matter, deep grey
nuclei, midbrain, brainstem and cerebellum. They are
morphologically and pathogenetically distinct from
periarterial or periarteriolar space expansion. They may
include a small area of cavitation but frequently do
not. Noncavitated lesions are recognizable as areas of
neuropil or white matter attenuation associated with
gliosis and loss of neuronal elements. They commonly
contain a variable number of reactive astrocytes, amoe-
boid microglia and siderophages and the pathogenesis
of microinfarction remains unclear. In the context of
cerebral amyloid angiopathy (CAA) they occur in the
cerebral cortex, particularly if there are associated fea-
tures of severe or complicated CAA (microaneurysms,
perivascular inflammation, etc.). When they do not
occur as part of the parenchymal sequelae of CAA it is
assumed that other factors lead to occlusion, or criti-
cally low flow, in small distal arterioles. Such factors
likely include intrinsic small vessel degenerative
changes (possibly related to systemic hypertension). As
such, microinfarcts can reasonably be included within
the spectrum of vascular lesions encompassed by the
term ‘small vessel disease’ (SVD).
Microinfarcts are reported to be associated with a
number of clinical and pathological observations in
older people. Virtually all such studies to date are based
on post-mortem associations because microinfarcts, as
defined above, are not demonstrated at magnetic field
strengths (i.e. 3Tesla and below) used currently in rou-
tine clinical magnetic resonance imaging (MRI) [3].
The term has, however, been applied to imaging stud-
ies, from the earliest use of computed tomography
brain scanning, in the context of lesions of several mil-
limetres in diameter so that there is a problematic
inconsistency in terminology between pathologists and
radiologists [4,5]. They are reported to relate to the
presence of macroscopic cerebral infarcts (both lacunes
and larger infarcts) and atherosclerosis of cerebral
arteries [6,7]. They are associated with cerebral atro-
phy, dementia and also cognitive decline in nonde-
mented people [8–11]. Larger numbers of microinfarcts
in an individual may increase the risk of dementia.
They are additionally associated with an increased risk
of depression in older people, especially if the burden of
disease is subcortical [12]. A large population-represen-
tative study (Honolulu Asia Ageing Study: HAAS) has
suggested that microinfarcts have a predominant signif-
icance in the pathological evaluation of small vessel
vascular lesions contributing to cognitive decline and
dementia [10].
MRC CFAS, a longitudinal, population-representative
cohort study of cognition and frailty in older people in
the UK, has contributed substantially to the emerging
consensus that vascular pathology is a major correlate
of cognitive decline and dementia in old people
[13,14]. Our previous analyses have shown that the
effect of vascular disease on cognition is primarily
mediated through SVD rather than the concept of mul-
ti-infarct dementia that emerged from studies published
in the 1970s [15,16]. SVD is considered to be the
pathological basis of the clinical diagnosis of Subcorti-
cal Ischaemic Encephalopathy in most cases [1]. CFAS
studies have previously used a modification of the Con-
sortium to Establish a Registry for Alzheimer’s Disease
(CERAD) neuropathology protocol to record and score
pathological changes in the brains donated by respon-
dents and their relatives. The CFAS working definition
of SVD has been based on the presence of any one of:
moderate or severe arteriosclerosis of parenchymal ves-
sels; lacunar infarcts (i.e. macroscopically identified old
ischaemic lesions <1 cm in diameter); severe white
matter lesions (WML; corresponding to Schelten’s
scores 5 and 6); and microinfarcts [13]. All these eval-
uations include compromises based on the methods
available and which are discussed below. However, the
CERAD protocol used was drafted prior to the emer-
gence of microinfarcts as an important pathology so
that this type of lesion did not have a specific data field
captured within the CFAS pathology data proforma
[17]. The core CERAD data set was accumulated from
multiple centres involving evaluations made by a num-
ber of different pathologists. Inter-rater reliability has
been established previously for core CERAD data items
(atrophy, neuritic plaques, tangles, Lewy bodies, etc.)
but not for microinfarcts [14]. Some pathologists
recorded microinfarcts as free text items but there was
no systematic approach and these data are previously
incomplete.
In this study the brain donations to three of the six
CFAS centres were re-evaluated by a single
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neuropathologist (SBW) to record the location and
number of microinfarcts in all the blocks used for
CERAD evaluations. These new data have allowed us
to address a number of important questions.
How are microinfarcts associated, in this population
representative cohort, with other types of small and
large vessel ischaemia? Does the addition of complete
data on microinfarcts alter previous conclusions about
SVD published by CFAS, in particular by increasing
the ascertainment of an SVD diagnosis, and in terms of
the impact on pathological correlates of dementia? Do the
findings and analyses offer useful insights into opera-
tionalizing the pathological evaluation of SVD?
Material and methods
Assessment of small vascular lesions
All brain donations (n = 331) corresponding to CFAS
data release 4.0 from 3 CFAS Centres (Cambridge,
Newcastle upon Tyne, Nottingham) were examined for
this study. These brains were prepared for archiving as
previously described [14]. One cerebral hemisphere was
dissected fresh (Cambridge, Newcastle upon Tyne) or
partially sampled (Nottingham) for rapid freezing and
storage. The remaining tissues were formalin fixed and
dissected and prepared for macroscopic and microscopic
brain examination using standard methods. For this
study, microinfarcts were detected using screening with
a low power objective (94 objective) on haematoxylin
and eosin (H&E) stained sections of formalin-fixed
paraffin-embedded tissue. All lesions observed were
then confirmed at higher power magnification. A
microinfarct diagnosis was confirmed for all lesions
smaller than 1 mm in diameter. Sections from the fol-
lowing nine brain regions were examined for microin-
farcts: frontal cortex, temporal cortex, parietal cortex,
occipital cortex, cingulate cortex, insular cortex, hip-
pocampus (level of lateral geniculate body), entorhinal
cortex and amygdala, cerebellar cortex. Sections from
the following four subcortical brain regions were exam-
ined for microscopic subcortical lesions: basal ganglia,
midbrain, pons and medulla. Examples of lesions identi-
fied in cortical and subcortical sites are shown in
Figure 1.
An indication of the severity and anatomical disper-
sion of lesions was recorded as the number of regions
in which microinfarcts and subcortical lesions were
present in each case. For the analysis in this study, we
have used the word ‘stage’ to encompass the number
of regions affected although we do not imply any hier-
archic element to the anatomical dispersion or severity
of microinfarcts.
Other small vessel disease
Existing CFAS data were used to define SVD in the
absence of either microinfarcts/subcortical lesions
detected in the review conducted for this analysis as
described above, or any previous microinfarct data that
had been recorded. Details of the definitions and tech-
niques used to detect these lesions are described previ-
ously. Briefly, severe or moderate arteriosclerosis was
evaluated by microscopy in H&E sections as thickened
vessel profiles with variable hyalinization of the muscle
media and loss of smooth muscle nuclei. Lacunes were
cystic lesions measuring less than 1 cm in diameter that
were observed at brain dissection by macroscopic
inspection. WMLs were detected by MRI scanning of 3
formalin fixed, 1 cm thick, coronal cerebral hemisphere
slices as previously described. Significant WML, in terms
of a CFAS diagnosis of SVD, corresponds to the presence
of WML at modified Schelten’s scale scores of 5 or 6 in
any of this sample. Scheltens’ score 5 implies the pres-
ence of at least one area of deep hemispheric white mat-
ter T2 signal attenuation greater than 11 mm in any
diameter. Scheltens’ score 6 refers to the presence of lar-
ger and more confluent areas of MRI white matter
attenuation. Previous work in CFAS including this
cohort of brain donors has shown that scores of 5 and
6 are significantly associated with risk of dementia [15].
Assessment of CAA
Data for CAA were available from existing CFAS data
collected by neuropathologists blind to clinical data
using immunohistochemical or tinctorial methods.
The severity of meningeal and parenchymal CAA was
scored semi-quantitatively according to the CERAD
protocol, as either ‘none’, ‘mild’, ‘moderate’ or ‘sev-
ere’, in the hippocampal, entorhinal and neocortical
regions. A final semi-quantitative score was obtained
by calculating the maximum score across these areas.
These scores were simplified for analysis: ‘severe’ was
merged with ‘moderate’, and ‘none’ was merged with
‘mild’.
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Assessment of clinical and other data
All CFAS brain donors underwent longitudinal assess-
ments in life using a standard interview battery. Existing
data relating to clinical diagnoses and self-reported risk
factors were available including dementia status at death
(based on data from the last assessment before death and
a Retrospective Informant Interview [RINI]), and any self-
reported medical history of angina, heart attack, stroke,
systemic hypertension or diabetes mellitus (DM). The
ApoEe4 status for each brain donor was known from pre-
vious genetic analyses. In the absence of formal gait-ana-
lysis data, a mobility score was created by combining
CFAS interview questions regarding mobility and ten-
dency to fall, and based on the last interview before death.
A semi-quantitative score of 0 was assigned if the partici-
pant was ambulant, score 1 if there were recent falls (de-
fined as more than one fall since previous interview), and
score 3 if the participant was chair or bed bound.
Statistical analysis and modelling of diagnostic protocols
Logistic regression analyses were used to verify the rela-
tionship between the presence of dementia and vascular
lesions. To study the relationship between mobility
scores and microinfarct stages, and between microinfarct
stages and WML scores, ordinal logistic regression analy-
ses were used. Because microinfarct stages are counts of
regions containing lesions, and were over-dispersed, neg-
ative binomial regression was used when assessing risk
factors for microinfarct stages. The effect of adding data
on microinfarcts into the definition of SVD was assessed
by comparing the logistic regression models with and
without microinfarcts based on area under receiver-oper-
ating characteristic curve (AUC). All tests were two-
tailed. Confidence intervals (95% CI) were calculated for
the odds ratio (OR), incidence rate ratio (IRR), b and
AUC. A P-value of less than 0.05 indicated statistical sig-
nificance. Statistical analyses were performed using sta-
tistical package STATA, version 12.
Results
Characteristics of the cohort regarding dementia
status
The demographic and pathological details of the cohort
are presented in Table 1. In 9% of respondents the
(a) (b)
(c) (d)
Figure 1. Photomicrographs of cortical and subcortical microinfarcts/microscopic lesions. Microinfarcts (block arrows) typically appear
as small localized areas of cortical rarefaction frequently in clear association with a small penetrating artery (arrow head) (a,b). In (c),
the microinfarct has a linear configuration extending towards the cortical surface (block arrows). There is eosinophilia and vessel wall
thickening of the penetrating arteries in the adjacent cortex typical of amyloid angiopathy (arrows). Basal ganglia lesions frequently
include a cystic component with variable attenuation of the contiguous neuropil (arrowhead) (d). [Colour figure can be viewed at
wileyonlinelibrary.com]
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dementia status was not clear from the data available
from respondent interviews and the RINI. Such cases
are not included in analyses related to dementia.
Relationship between vascular neuropathology and
clinical status
Overall 36% of brains contained at least one microin-
farct. The frequency of microinfarcts in cortical and
subcortical regions according to dementia status is
shown in Table 2. To explore whether microinfarcts
were related to dementia, logistic regression analyses
were performed with dementia status as dependent
variable and microinfarct stages as independent vari-
able controlling for sex and age at death (Table 3).
More regions with cortical microinfarcts were signifi-
cantly associated with clinical dementia but neither
subcortical lesion burden nor total burden (combined
cortical and subcortical) showed a significant relation-
ship with dementia status.
Using the mobility scores generated from the inter-
view data as the dependent variable in ordinal logistic
regression analysis, and microinfarct stages as indepen-
dent variables, higher microinfarct stages in cortical,
subcortical and total regions were significantly related
to impaired mobility and falls. The analysis was con-
trolled by age of death, sex, education and gap between
last mobility assessment and death (Table 3).
Relationship between vascular neuropathology and
risk factors
The prevalence of self-reported hypertension (HTN) was
39%, Diabetes mellitus (DM) 11%, angina 19%,
myocardial infarct (MI) 12% and cerebrovascular acci-
dent (CVA) 15% in this cohort of CFAS respondents.
Twenty-three percent of the respondents had at least
one APOEe4 allele. Moderate or severe CAA was pre-
sent in 22% of the brains. Negative binomial regression
was used to investigate possible risk factors for microin-
farction. Microinfarcts stages were selected as depen-
dent variables and angina, CVA, DM, HTN, MI,
presence of at least one APOEe4 allele, and moderate
or severe CAA, were selected as independent variables.
All analyses were controlled by age at death and sex
(Table 4). There was a significant relationship between
the presence of microinfarcts in both cortical and sub-
cortical locations and a reported history of CVA. A rela-
tionship with hypertension was demonstrated for total
lesions although it was not significantly associated
when analysis is performed separately for cortical and
subcortical regions.
Table 1. Demographic, cognitive and mobility profile according to clinical dementia status
No dementia (n = 126) Dementia (n = 174) Not determined (n = 31)
Women* 63 (50) 119 (68) 16 (52)
Age at death† 84 (76–89) 89 (84–93) 86 (83–89)
Years since last cognitive assessment† 1.2 (0.7–2.0) 2.3 (1.0–3.7) 2.1 (1.8–3.4)
MMSE at last assessment† 26 (23–28) 14 (8–20) 27 (22–28)
Years since last mobility assessment† 1.3 (0.7–2.2) 3.1 (1.8–3.4) 0 (0)
Mobility score at last assessment† 0 (0–1) 0 (0–0) 0 (0–1)
*n (%).
†Median (inter quartile range).
Table 2. Microinfarct distribution according to clinical dementia
status
Region*
No dementia
(n = 126)
Dementia
(n = 174)
Not determined
(n = 31)
Cortical microinfarcts† 0 (0; 3) 0 (0; 6) 0 (0; 6)
Frontal cortex* 5 (4.0) 15 (8.6) 3 (9.7)
Temporal cortex* 1 (0.8) 9 (5.2) 1 (3.2)
Parietal cortex* 4 (3.2) 10 (5.8) 1 (3.2)
Occipital cortex* 12 (9.5) 13 (7.5) 5 (16.1)
Cingulate cortex* 0 4 (2.3) 0
Insular cortex* 0 1 (0.6) 1 (3.2)
Hippocampal cortex* 5 (4.0) 6 (3.5) 1 (3.2)
Entorhinal cortex* 0 11 (6.3) 1 (3.2)
Cerebellar cortex* 6 (4.8) 6 (3.5) 1 (3.2)
Subcortical lacunar
infarcts†
0 (0; 2) 0 (0; 3) 0 (0; 2)
Basal ganglia* 13 (10.3) 24 (13.8) 4 (12.9)
Midbrain* 2 (1.6) 1 (0.6) 1 (3.2)
Pons* 4 (3.2) 7 (4.0) 1 (3.2)
Medulla* 1 (0.8) 1 (0.6) 0
Total microinfarcts† 0 (0; 4) 0 (0; 6) 0 (0; 7)
*Number of brains with one or more microinfarct per region (%).
†Median number of affected regions (minimum; maximum).
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Relationship between vascular neuropathology and
MRI WML
MRI evaluation of WML using Schelten’s modified score
in this cohort showed a deep WML median score of 3
(range 0–6) and a periventricular (PV) WML median
score of 2 (range 0–3). To explore a relationship
between MRI WML and microinfarcts ordinal logistic
regression analyses were used with deep WML and
PVWML scores as dependent variables. Microinfarct
stages were selected as independent variable, and all
analyses were controlled by age of death and sex
(Table 5).
Cortical microinfarcts in more regions was signifi-
cantly related to higher deep WML scores.
Effect of the inclusion of microinfarcts as a
component of SVD in relation to dementia status
Among the 300 participants in whom clinical dementia
status was established, SVD was present in 55 partici-
pants without dementia and 109 with dementia. The
addition of microinfarcts into the operational definition
of SVD identified 11 additional respondents with SVD:
seven of these had clinical dementia and four did not.
To investigate the effect of adding data on microinfarcts
into the definition of SVD in relation to clinical demen-
tia status, we compared the area under ROC curve
(AUC) for two logistic regression models: Model 1 used
the previously defined CFAS SVD status without
microinfarct data; Model 2 incorporated microinfarct
data into the previously defined CFAS SVD status. Both
models used clinical dementia status as dependent vari-
able and SVD as independent variable, and were con-
trolled for age of death and sex. SVD was significantly
related to dementia status in both models but the two
AUC were not significantly different.
Analysis of components of the SVD diagnosis in the
design of diagnostic protocols for the pathological
evaluation of SVD
Since the effect of microinfarcts on dementia status was
modest we additionally explored the contribution of
each component used in the operational definition of
significant SVD and both dementia status and mobility.
The contribution of the presence of each SVD compo-
nent (lacunes, cortical microinfarcts, subcortical
lesions, moderate or severe arteriolar sclerosis and
WML) and their relationship with dementia and mobil-
ity status, controlled by sex and age, is demonstrated
in Table 6. When analysing the contribution of each
Table 3. Logistic regression analysis of the relationship between microinfarct stages and clinical dementia status or mobility
Stages
Dementia status Mobility score
OR 95% CI (OR) P OR 95% CI (OR) P
Cortical 1.41 (1.02; 1.96) 0.038 1.36 (1.05; 1.74) 0.018
Subcortical 1.05 (0.99; 2.72) 0.846 1.96 (1.11; 3.43 0.020
Total 1.30 (0.99; 1.69) 0.056 1.39 (1.44; 1.74) 0.004
Table 4. Negative binomial regression analyses on the relationship between cardiovascular risk factors and microinfarcts
Risk factors IRR
95% CI (IRR)
P IRR
95% CI (IRR)
P IRR
95% CI (IRR)
PCortical microinfarct Subcortical lesion Total microinfarct
Angina 1.53 (0.90; 2.60) 0.110 0.96 (0.47; 1.94) 0.910 1.35 (0.86; 2.13) 0.200
Stroke 2.74 (1.62; 4.64) <0.001 1.91 (1.02; 3.59) 0.040 2.47 (1.58; 3.87) <0.001
DM 0.75 (0.34; 1.63) 0.460 0.71 (0.25; 2.02) 0.520 0.72 (0.37; 1.40) 0.330
HTN 1.42 (0.89; 2.26) 0.140 1.56 (0.90; 2.69) 0.110 1.47 (1.00; 2.18) 0.050
MI 1.42 (0.75; 2.67) 0.280 1.01 (0.45; 2.29) 0.980 1.29 (0.75; 2.22) 0.360
e4 0.57 (0.31; 1.05) 0.070 1.35 (0.68; 2.67) 0.400 0.78 (0.48; 1.27) 0.310
CAA 1.47 (0.89; 2.44) 0.130 1.25 (0.68; 2.29) 0.470 1.39 (0.90; 2.13) 0.130
DM, diabetes mellitus; HTN, systemic hypertension; MI, myocardial infarction; e4, 1 or 2 Apolipoprotein E e4 alleles; CAA, cerebral amy-
loid angiopathy.
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SVD component independently, only white matter
pallor was significantly related to dementia status, inde-
pendently of age and sex. The only single lesion type
significantly associated with mobility was microinfarc-
tion. Analysis of the effect of combinations of lesion
types suggests that excluding arteriosclerosis from the
working definition of SVD has a very limited impact on
the relationship with dementia or with mobility.
Assessment of arteriosclerosis is based on distinguishing
relative severity and has not been operationalized or
assessed by inter-rater reliability studies. A diagnostic
protocol based exclusively on the presence or absence
of the lesions considered to result from SVD,
rather than on the subjective assessment of vessels
themselves, is likely to be a more robust approach for
pathological studies.
Discussion
The analysis confirms that microinfarction is a common
finding in an unselected, population-representative,
cohort of older brain donors in the UK among whom
more than 75% were aged over 80 years at death. More
than one-third of the cohort had at least one lesion. Our
data analysis supports the hypothesis that such lesions
are clinically relevant in terms of the risk of dementia
and of impaired mobility and falling in old age, and thus
we conclude that microinfarcts significantly contribute
to physical and mental frailty in the elderly. These data
are very similar to those reported in a large community-
based sample (Religious Orders Study) in which 30% of
brain donors had microinfarcts among whom 45% did
not have any macroscopic infarction [18].
Table 5. Ordinal logistic regression analyses on the relationship between microinfarct stage and MRI WML
Stages
Deep WML Periventricular WML
OR 95% CI (OR) P OR 95% CI (OR) P
Cortical 1.31 (1.01; 1.70) 0.044 1.17 (0.89; 1.54) 0.264
Subcortical 1.35 (0.83; 2.19) 0.228 1.80 (1.09; 2.97) 0.022
Total 1.30 (1.04; 1.62) 0.023 1.27 (1.01; 1.61) 0.045
Table 6. Logistic regression analysis of the relationship between the individual components, and possible combinations of components,
used to define SVD and clinical outcomes. p values in bold type indicate statistically significant association with clinical outcome.
SVD definition Total (n)
Dementia Impaired mobility
With dementia
(n) OR 95% CI (OR) P
Frequent
falls (n)
Chair/bed
(n) OR 95% CI (OR) P
A 68 36 0.86 (0.46; 1.60) 0.630 17 5 1.61 (0.88; 2.95) 0.119
L 63 35 1.45 (0.75; 2.82) 0.270 14 6 1.76 (0.95; 3.26) 0.075
M 118 69 1.48 (0.88; 2.48) 0.143 28 9 2.07 (1.21; 3.52) 0.008
W 137 86 1.76 (1.06; 2.93) 0.030 24 8 1.01 (0.59; 1.73) 0.966
MA 152 86 1.24 (0.75; 2.03) 0.404 35 12 2.26 (1.32; 3.85) 0.003
MW 187 112 1.95 (1.18; 3.23) 0.010 35 11 1.18 (0.69; 2.01) 0.543
WA 163 100 1.85 (1.12; 3.06) 0.016 28 11 1.06 (0.63; 1.80) 0.827
LA 99 53 1.10 (0.63; 1.90) 0.742 22 7 1.44 (0.84; 2.47) 0.190
LM 157 91 1.58 (0.96; 2.60) 0.072 35 13 2.17 (1.28; 3.68) 0.004
LW 167 101 1.89 (1.15; 3.12) 0.013 32 12 1.37 (0.81; 2.31) 0.237
LMA 173 99 1.46 (0.89; 2.40) 0.132 38 14 2.18 (1.28; 3.74) 0.004
LMW 210 124 2.12 (1.26; 3.58) 0.005 40 14 1.38 (0.79; 2.40) 0.252
LWA 179 108 1.88 (1.14; 3.11) 0.014 32 13 1.20 (0.71; 2.02) 0.505
WMA 203 120 1.99 (1.19; 3.32) 0.009 37 13 1.19 (0.69; 2.05) 0.525
WMLA 217 128 2.13 (1.25; 3.62) 0.005 40 15 1.31 (0.75; 2.30) 0.339
For dementia all models including white matter lesions are significantly predictive; For impaired mobility only models including subcorti-
cal microinfarcts are significantly predictive.
A, moderate or severe arteriosclerosis; L, lacunes; M, microinfarcts; W, deep white matter lesions.
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The burden of microinfarcts is associated with other
manifestations of cerebrovascular pathology [2,18]. At
the present time the pathophysiological mechanisms
linking these subtypes of vascular pathology are poorly
understood. We demonstrate an association both with
a clinical history of stroke and with hypertension.
Hypertension is certainly considered to be a major
underlying risk factor for cerebral SVD but clinical
stroke is diverse both in terms of ischaemic and haem-
orrhagic pathophysiology and, for ischaemic stroke, in
terms of the contributions of intrinsic cerebrovascular
disease compared to carotid or cardiac microemboliza-
tion [1]. Within the constellation of pathologies that
we have combined into a global concept of SVD the
underlying mechanisms that cause microinfarcts, white
matter attenuation and lacunes are not precisely
defined. Other work has suggested that cerebral
atherosclerosis is linked with microinfarction, whereas
arteriosclerosis is more linked to lacunes. These find-
ings potentially imply a role for artery-to-artery
microembolization as a significant pathogenetic event
[7]. There is further supportive evidence based on an
increase in haemostatic biomarkers in people with
microinfarction [19]. There are significant limitations
on the utility of human post-mortem-based observa-
tions in determining the underlying mechanisms that
give rise to WMLs, lacunes, microbleeds and microin-
farcts so that the development of preclinical models is
an urgent priority to accelerate effective translational
research towards therapies with the potential to modify
these different types of tissue injury.
Our working definition of SVD conflates a measure of
blood vessel damage (severity of arteriosclerosis) with
several pathologies assumed to represent parenchymal
sequelae of presumed acute (microinfarcts, lacunes)
and chronic (WMLs) ischaemia. We have used multi-
variate analysis to try and tease apart the impact of
these various types of lesion on clinical outcomes and
the association with risk factors but acknowledge that
there are likely to be major common underlying mech-
anisms so that they are not entirely independent.
There is no established consensus on the evaluation
of lesions that fall within the spectrum of SVD [20–22].
Despite this a number of studies, including MRC CFAS,
have shown that SVD is a more important risk factor
for cognitive decline and dementia than large ischaemic
lesions [15]. A single report has addressed the implica-
tions of encountering microinfarcts in the very limited
sample of brain tissue that is routinely evaluated by
microscopy in modern neuropathology practice for the
diagnosis of dementing disorders. This study calculated
that if 1 microinfarct is present in any of the sections
examined from nine routinely sampled brain regions
(each section likely to be ~4–6 cm2 in surface area and
4–8 lm thick, i.e. up to 0.5 mm3 in volume) this likely
corresponds to around 550–1100 such lesions
throughout the whole brain [23]. There is therefore an
important issue to resolve in terms of how to opera-
tionalize the evaluation of microinfarcts, and how to
assimilate such data into the wider evaluation and defi-
nition of SVD. In the basal ganglia small parenchymal
lesions are especially problematic to classify. The possi-
bility of three types of macroscopic lacune has been
proposed (true lacunar infarcts, enlarged perivascular
spaces, small apoplectic cysts) and all three are com-
mon in the deep grey nuclei [24]. Furthermore, there
appears to be some continuity between microscopic foci
and those visible to the naked eye. For this reason
microinfarcts and other microscopic ischaemic vascular
lesions in this region were grouped together as ‘subcor-
tical lesions’ for the purposes of this study if they were
not previously detected by gross examination as
lacunes or etat cribre.
In view of the above considerations, we have exam-
ined our data to see if the assertion arising from the
Honolulu Asian Ageing Study, that microinfarcts are of
particular significance as predictors of clinically
expressed SVD, is justified in this cohort [10]. We show
that the inclusion of microinfarcts does modestly
increase the number of brains examined to which a
diagnosis of SVD can be assigned using our criteria.
However, this added individuals both with and without
dementia, and the overall impact in terms of the predic-
tive power of the SVD diagnosis was not significantly
changed.
We therefore propose that a pathological concept of
SVD based on a constellation of lesion types remains
the most valid approach to capturing this pathological
state for clinicopathological correlation and to study
disease mechanisms in post-mortem brain samples.
Because WML remain an important lesion type in this
analysis, and it is necessary to stratify cases by severity
and lesion burden, it is reasonable to assert that neu-
ropathological protocols that do not adequately assess
WML are incomplete in terms of assessing SVD brain
pathology in older people. This is most conveniently
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and efficiently achieved using post-mortem MRI which
is presently not widely available to neuropathology lab-
oratories [25]. We also raise the possibility that includ-
ing the direct evaluation of arteriosclerosis may not be
an essential element of the pathological constellation of
SVD. Including arteriosclerosis requires a subjective
evaluation of severity and may not be so robust to
interobserver agreement. In contrast, the presence of
microinfarction, lacunar infarction and extensive
WMLs as demonstrated by MRI are largely categorical
measures.
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